BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 27635465)

  • 1. Prevalence and risk factors for left ventricular diastolic dysfunction in a scleroderma cohort.
    Vemulapalli S; Cohen L; Hsu V
    Scand J Rheumatol; 2017 Jul; 46(4):281-287. PubMed ID: 27635465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors for left ventricular diastolic dysfunction in systemic sclerosis: a multi-center study of CRDC cohort in China.
    Hui M; Zhou J; Zhang L; Duan X; Li M; Wang Q; Zhao J; Hou Y; Xu D; Zeng X
    Clin Rheumatol; 2021 Nov; 40(11):4589-4596. PubMed ID: 34142296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining the necessity for right heart catheterization in pulmonary hypertension associated with connective tissue diseases assessed by echocardiography.
    Choi JH; Joo SJ; Kim J
    Int J Rheum Dis; 2016 Jan; 19(1):65-73. PubMed ID: 26820839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of Left Ventricular Diastolic Dysfunction to Survival and Breathlessness in Systemic Sclerosis-Associated Interstitial Lung Disease.
    Fairley JL; Hansen D; Burns A; Prior D; La Gerche A; Morrisroe K; Stevens W; Nikpour M; Ross LJ
    J Rheumatol; 2024 May; 51(5):495-504. PubMed ID: 38224991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
    Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
    Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension.
    Antoniou KM; Margaritopoulos GA; Goh NS; Karagiannis K; Desai SR; Nicholson AG; Siafakas NM; Coghlan JG; Denton CP; Hansell DM; Wells AU
    Arthritis Rheumatol; 2016 Apr; 68(4):1004-12. PubMed ID: 26636545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
    Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
    Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.
    Volkmann ER; Saggar R; Khanna D; Torres B; Flora A; Yoder L; Clements PJ; Elashoff RM; Ross DJ; Agrawal H; Borazan N; Furst DE; Saggar R
    Arthritis Rheumatol; 2014 Jul; 66(7):1900-8. PubMed ID: 24729406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of occult left ventricular diastolic dysfunction detected by exercise stress test in systemic sclerosis.
    Mohri T; Goda A; Takeuchi K; Kikuchi H; Inami T; Kohno T; Sakata K; Soejima K; Satoh T
    Sci Rep; 2022 Feb; 12(1):2423. PubMed ID: 35165319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment for Pulmonary Artery Hypertension Using Clinical and Echocardiographic Criteria in Patients With Systemic Sclerosis.
    Methia N; Latreche S; Ait Mokhtar O; Monsuez JJ; Benkhedda S
    Am J Med Sci; 2016 Oct; 352(4):343-347. PubMed ID: 27776714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
    D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
    Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired fasting glucose and left ventricular diastolic dysfunction in middle-age adults: a retrospective cross-sectional analysis of 2971 subjects.
    Milwidsky A; Maor E; Kivity S; Berkovitch A; Zekry SB; Tenenbaum A; Fisman EZ; Erez A; Segev S; Sidi Y; Goldenberg I; Kuperstein R
    Cardiovasc Diabetol; 2015 Sep; 14():119. PubMed ID: 26369690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Prevalence of Acute Exacerbation of Interstitial Lung Disease in Japanese Patients with Systemic Sclerosis.
    Tomiyama F; Watanabe R; Ishii T; Kamogawa Y; Fujita Y; Shirota Y; Sugimura K; Fujii H; Harigae H
    Tohoku J Exp Med; 2016 Aug; 239(4):297-305. PubMed ID: 27487743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, Treatment, and Outcomes of Coexistent Pulmonary Hypertension and Interstitial Lung Disease in Systemic Sclerosis.
    Young A; Vummidi D; Visovatti S; Homer K; Wilhalme H; White ES; Flaherty K; McLaughlin V; Khanna D
    Arthritis Rheumatol; 2019 Aug; 71(8):1339-1349. PubMed ID: 30762947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on pulmonary complications of systemic sclerosis in eastern India.
    Ghosh A; Banerjee A; Biswas AK
    Indian J Chest Dis Allied Sci; 2014; 56(4):231-5. PubMed ID: 25962196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiendothelial cells antibodies in patients with systemic sclerosis in relation to pulmonary hypertension and lung fibrosis.
    Lewandowska K; Ciurzynski M; Gorska E; Bienias P; Irzyk K; Siwicka M; Zycinska K; Pruszczyk P; Demkow U
    Adv Exp Med Biol; 2013; 756():147-53. PubMed ID: 22836630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort.
    Noviani M; Saffari SE; Tan JL; Yip JWL; Teng GG; Law WG; Chan GYL; Santosa A; Lim AYN; Hong C; Ng SA; Tay ELW; Ruan W; Yap J; Low AHL
    Semin Arthritis Rheum; 2020 Jun; 50(3):473-479. PubMed ID: 31810742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular diastolic dysfunction in systemic sclerosis: Clinical, immunological and survival differences in the Spanish RESCLE registry.
    González García A; Fabregate M; Manzano L; Guillén Del Castillo A; Rubio Rivas M; Argibay A; Marín Ballvé A; Rodríguez Pintó I; Pla Salas X; Marí-Alfonso B; Callejas Moraga E; Colunga Argüelles D; Sáez Comet L; González-Echávarri C; Ortego-Centeno N; Vargas Hitos JA; Todolí Parra JA; Trapiella Martínez L; Herranz Marín MT; Freire M; Chamorro AJ; Perales Fraile I; Madroñero Vuelta AB; Sánchez Trigo S; Tolosa Vilella C; Fonollosa Pla V; Simeón Aznar CP;
    Semin Arthritis Rheum; 2022 Aug; 55():152033. PubMed ID: 35691226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis.
    de Groote P; Gressin V; Hachulla E; Carpentier P; Guillevin L; Kahan A; Cabane J; Francès C; Lamblin N; Diot E; Patat F; Sibilia J; Petit H; Cracowski JL; Clerson P; Humbert M;
    Ann Rheum Dis; 2008 Jan; 67(1):31-6. PubMed ID: 17267515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between left ventricular diastolic dysfunction and six minute walk test in patients with systemic sclerosis.
    Akdogan A; Kaya EB; Sahin A; Okutucu S; Yakut E; Kalyoncu U; Aksoy H; Karadag O; Calguneri M; Tokgozoglu L; Kiraz S; Ertenli I
    Int J Rheum Dis; 2011 Oct; 14(4):379-83. PubMed ID: 22004236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.